tiprankstipranks
Trending News
More News >
Leonardo Drs, Inc. (DRS)
:DRS
Advertisement

Leonardo Drs (DRS) AI Stock Analysis

Compare
1,035 Followers

Top Page

DRS

Leonardo Drs

(NASDAQ:DRS)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
$37.00
▲(9.08% Upside)
Leonardo DRS shows strong financial performance and a positive outlook from its earnings call, driving the score. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Leonardo DRS's products and services, enhancing its market position and financial stability.
Strong Backlog
An increasing backlog provides revenue visibility and stability, supporting long-term growth and operational planning.
Leadership Transition
The appointment of a new CEO can bring fresh strategic direction and innovation, potentially enhancing company performance and adaptability.
Negative Factors
Margin Pressure
Margin contraction due to increased R&D and less efficient execution could impact profitability, requiring careful cost management.
Supply Chain Challenges
Supply chain issues, particularly with critical materials, can disrupt production and delivery schedules, affecting revenue and customer satisfaction.
Government Shutdown Concerns
Prolonged government shutdowns can delay contract awards and payments, affecting cash flow and financial planning.

Leonardo Drs (DRS) vs. SPDR S&P 500 ETF (SPY)

Leonardo Drs Business Overview & Revenue Model

Company DescriptionLeonardo DRS, Inc. is a leading provider of advanced technology solutions primarily serving the defense and aerospace sectors. The company specializes in designing and manufacturing innovative products and systems in areas such as defense electronics, avionics, and critical communications. With a focus on enhancing military capabilities and ensuring the safety and security of personnel, DRS offers a wide range of core products including thermal imaging systems, electronic warfare solutions, and integrated mission systems, catering to both domestic and international clients.
How the Company Makes MoneyLeonardo DRS generates revenue through multiple key streams, primarily from the sale of defense electronics and systems to government and military organizations. The company earns money by securing contracts with the U.S. Department of Defense and various allied nations, often through competitive bidding processes. Additionally, revenue is generated from long-term support and maintenance contracts for their products, which provide ongoing income. Strategic partnerships with other defense contractors and technology firms also contribute to revenue growth, allowing DRS to offer integrated solutions and access new markets. Furthermore, the company invests in research and development to innovate and expand its product offerings, positioning itself favorably within the defense technology landscape.

Leonardo Drs Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 31, 2026
Earnings Call Sentiment Positive
The earnings call reflects a positive outlook with strong bookings, revenue, and profit growth, alongside strategic leadership transitions. However, challenges such as margin pressure, potential impacts of the government shutdown, and supply chain issues remain concerns.
Q3-2025 Updates
Positive Updates
Strong Bookings and Backlog
The company secured $1.3 billion in bookings in Q3, resulting in a 1.4x book-to-bill ratio, with a year-to-date ratio of 1.2x. Total backlog increased to $8.9 billion, up 8% year-over-year, and funded backlog grew by 20%.
Revenue and Profit Growth
Quarterly revenue grew by 18% year-over-year to $960 million, with adjusted EBITDA up 17%. Adjusted diluted EPS increased by 21%.
Key Program Wins
Awarded over $250 million in contracts for ground-based counter UAS and short-range air defense programs. IMS segment revenue grew by 34%.
New CEO and Leadership Transition
John Baylouny named new CEO, effective January 1, 2026, with Fran Townsend elected as the new Chair of the Board.
Negative Updates
Margin Pressure
Adjusted EBITDA margin slightly contracted by 10 basis points due to increased R&D investments, less favorable program mix, and less efficient program execution.
Government Shutdown Concerns
Ongoing federal government shutdown could impact awards and payment schedules if prolonged.
Supply Chain Challenges
Continued challenges with germanium supply chain, though steps are being taken to secure future supply.
Company Guidance
During the Leonardo DRS Third Quarter Fiscal Year 2025 Earnings Conference Call, management provided several key financial metrics and forward-looking guidance. The company reported strong financial performance with a quarterly revenue growth of 18% year-over-year, reaching $960 million, and an adjusted EBITDA increase of 17%, totaling $117 million. The book-to-bill ratio was robust at 1.4x for the quarter, contributing to a year-to-date ratio of 1.2x, and the total backlog rose to $8.9 billion, up 8% year-over-year. Funded backlog saw a remarkable 20% year-over-year increase. The company updated its full-year revenue growth expectations to a range of 10% to 11% and maintained its adjusted EBITDA guidance between $437 million and $453 million. Additionally, adjusted diluted EPS rose by 21%, and free cash flow significantly exceeded prior year levels. Management remains focused on navigating a dynamic market environment, with ongoing investments in internal research and development continuing to impact margins.

Leonardo Drs Financial Statement Overview

Summary
Leonardo DRS demonstrates strong financial health with consistent revenue and profit growth, low leverage, and robust cash flow generation. However, slight pressure on operational margins warrants attention.
Income Statement
85
Very Positive
Leonardo DRS shows strong revenue growth with a TTM increase of 4.33% and consistent improvement in gross profit margin, now at 23.40%. The net profit margin has also improved to 7.43%, indicating enhanced profitability. However, the EBIT and EBITDA margins have slightly decreased compared to previous years, suggesting some operational cost pressures.
Balance Sheet
78
Positive
The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.13, indicating low leverage. Return on equity is solid at 10.22%, reflecting efficient use of equity. The equity ratio stands at 62.37%, showcasing a strong equity base relative to total assets.
Cash Flow
80
Positive
Leonardo DRS has demonstrated robust free cash flow growth of 12.77% in the TTM period, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.45, suggesting efficient conversion of income into cash. The free cash flow to net income ratio is 0.69, reflecting a healthy cash flow position relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.57B3.23B2.83B2.69B2.88B2.78B
Gross Profit835.00M736.00M648.00M575.00M547.00M494.00M
EBITDA426.00M376.00M313.00M624.00M293.00M229.00M
Net Income265.00M213.00M168.00M405.00M154.00M85.00M
Balance Sheet
Total Assets4.25B4.18B3.92B3.68B3.07B2.96B
Cash, Cash Equivalents and Short-Term Investments309.00M598.00M467.00M306.00M240.00M61.00M
Total Debt471.00M458.00M497.00M487.00M490.00M530.00M
Total Liabilities1.60B1.63B1.60B1.55B1.48B1.53B
Stockholders Equity2.65B2.56B2.33B2.13B1.59B1.43B
Cash Flow
Free Cash Flow265.00M186.00M145.00M-32.00M118.00M69.00M
Operating Cash Flow384.00M271.00M205.00M33.00M178.00M125.00M
Investing Cash Flow-134.00M-84.00M-59.00M436.00M39.00M-70.00M
Financing Cash Flow-139.00M-56.00M15.00M-403.00M-38.00M-80.00M

Leonardo Drs Technical Analysis

Technical Analysis Sentiment
Negative
Last Price33.92
Price Trends
50DMA
38.06
Negative
100DMA
40.32
Negative
200DMA
39.44
Negative
Market Momentum
MACD
-1.06
Negative
RSI
39.52
Neutral
STOCH
59.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DRS, the sentiment is Negative. The current price of 33.92 is below the 20-day moving average (MA) of 34.06, below the 50-day MA of 38.06, and below the 200-day MA of 39.44, indicating a bearish trend. The MACD of -1.06 indicates Negative momentum. The RSI at 39.52 is Neutral, neither overbought nor oversold. The STOCH value of 59.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DRS.

Leonardo Drs Risk Analysis

Leonardo Drs disclosed 55 risk factors in its most recent earnings report. Leonardo Drs reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leonardo Drs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$14.71B18.3611.46%0.10%1.83%-0.73%
73
Outperform
$16.26B53.2026.69%0.56%14.01%10.92%
73
Outperform
$7.53B32.4212.09%0.49%7.11%13.43%
69
Neutral
$9.02B34.3810.35%1.06%12.27%33.16%
69
Neutral
$11.95B21.0412.39%1.72%2.60%-18.22%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$12.92B622.961.20%14.00%23.78%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DRS
Leonardo Drs
33.92
0.15
0.44%
HII
Huntington Ingalls
315.88
127.05
67.28%
KTOS
Kratos Defense
77.03
49.80
182.89%
MOG.A
Moog
235.30
26.37
12.62%
TXT
Textron
84.41
2.07
2.51%
BWXT
BWX Technologies
178.75
57.49
47.41%

Leonardo Drs Corporate Events

DividendsBusiness Operations and StrategyFinancial Disclosures
Leonardo DRS Reports Strong Q3 2025 Financial Results
Positive
Oct 29, 2025

Leonardo DRS reported strong financial results for the third quarter of 2025, with revenue increasing by 18% year-over-year to $960 million. The company also saw a 26% rise in net earnings and a 17% increase in adjusted EBITDA. The growth was driven by strong demand across its product lines, particularly in electric power and propulsion programs. The company declared a $0.09 cash dividend per share and made strategic investments, including increasing its stake in Hoverfly Technologies to 25%.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025